Skip to content

Clinical trials

Phase 1/2 Amyotrophic Lateral Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyotrophic Lateral Sclerosis Phase: Phase 1/2 Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20083
20091
20101
20131
20141
20161
20171
20181
20191
20201
20211
20223
20231
20245
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Enrolling by invitation3
Active, not recruiting3
Recruiting3
Terminated2
Unknown status2
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
n-Lorem Foundation7
Phoenix Neurological Associates, LTD3
Bennett, James P., Jr., M.D., Ph.D.2
Flex Pharma, Inc.2
Amydis Inc.1
Amylyx Pharmaceuticals Inc.1
Ashvattha Therapeutics, Inc.1
Biogen1
Duke University1
Helixmith Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyotrophic Lateral Sclerosis31
Alzheimer Disease2
Fasciculation2
Motor Neuron Disease2
Neurodegenerative Diseases2
Neuromuscular Diseases2
Parkinson Disease2
Cerebral Palsy1
Cognitive Dysfunction1
Dementia1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.